Save time and jump to the most important pieces.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 11/4/2024 | $300.00 → $275.00 | Buy | Loop Capital | |
| 11/1/2024 | $203.00 → $215.00 | Hold | Maxim Group | |
| 10/25/2024 | $200.00 | Sector Weight → Underweight | KeyBanc Capital Markets | |
| 10/22/2024 | $168.00 | Mkt Perform | Bernstein | |
| 10/18/2024 | $165.00 → $190.00 | Buy | BofA Securities | |
| 10/11/2024 | $135.00 → $150.00 | Buy | Goldman | |
| 10/7/2024 | $145.00 | Neutral → Outperform | Macquarie | |
| 10/7/2024 | $205.00 → $212.92 | Buy → Hold | Jefferies |
NEW YORK, Nov. 1, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the Dow Jones Industrial Average (DJIA) and Dow Jones Utility Average (DJUA) effective prior to the open of trading on Friday, November 8: NVIDIA Corp. (NASD:NVDA) will replace Intel Corp. (NASD:INTC), and The Sherwin-Williams Co. (NYSE:SHW) will replace Dow Inc. (NYSE:DOW) in the Dow Jones Industrial Average. The index changes were initiated to ensure a more representative exposure to the semiconductors industry and the materials sector respectively. The DJIA is a price weighted index, and thus persistently lower priced stocks have a minimal impact on the index. Dow Inc. is also the smallest com
Alibaba Group Holding Limited (NYSE: BABA and HKEX: 9988 (HKD Counter) and 89988 (RMB Counter), "Alibaba" or "Alibaba Group") today announced that it will report its unaudited financial results for the quarter ended September 30, 2024 before the U.S. market opens on Friday, November 15, 2024, and will hold a conference call to discuss the financial results at 7:30 a.m. U.S. Eastern Time (8:30 p.m. Hong Kong Time) the same day. All participants must pre-register to join this conference call using the Participant Registration link below: English: https://s1.c-conf.com/diamondpass/10042440-pohtg.html Chinese: https://s1.c-conf.com/diamondpass/10042441-ywtss.html Upon registration, each part
iPhone drives record September quarter revenue Services revenue reaches new all-time high Apple® today announced financial results for its fiscal 2024 fourth quarter ended September 28, 2024. The Company posted quarterly revenue of $94.9 billion, up 6 percent year over year, and quarterly diluted earnings per share of $0.97. Diluted earnings per share was $1.64,1 up 12 percent year over year when excluding the one-time charge recognized during the fourth quarter of 2024 related to the impact of the reversal of the European General Court's State Aid decision. "Today Apple is reporting a new September quarter revenue record of $94.9 billion, up 6 percent from a year ago," said Tim Cook, Ap
Alibaba Group Holding Limited (NYSE: BABA and HKEX: 9988 (HKD Counter) and 89988 (RMB Counter), "Alibaba" or "Alibaba Group") today announced that it will report its unaudited financial results for the quarter ended September 30, 2024 before the U.S. market opens on Friday, November 15, 2024, and will hold a conference call to discuss the financial results at 7:30 a.m. U.S. Eastern Time (8:30 p.m. Hong Kong Time) the same day. All participants must pre-register to join this conference call using the Participant Registration link below: English: https://s1.c-conf.com/diamondpass/10042440-pohtg.html Chinese: https://s1.c-conf.com/diamondpass/10042441-ywtss.html Upon registration, each part
iPhone drives record September quarter revenue Services revenue reaches new all-time high Apple® today announced financial results for its fiscal 2024 fourth quarter ended September 28, 2024. The Company posted quarterly revenue of $94.9 billion, up 6 percent year over year, and quarterly diluted earnings per share of $0.97. Diluted earnings per share was $1.64,1 up 12 percent year over year when excluding the one-time charge recognized during the fourth quarter of 2024 related to the impact of the reversal of the European General Court's State Aid decision. "Today Apple is reporting a new September quarter revenue record of $94.9 billion, up 6 percent from a year ago," said Tim Cook, Ap
IBSRELA generates $40.6 million in net product sales revenue; Company expects full year 2024 IBSRELA net sales revenue to be between $145 and $150 million XPHOZAH generates $51.5 million in net product sales revenue Company ends Q3 with approximately $190 million in cash, cash equivalents and investments Conference call scheduled for 4:30 PM Eastern Time WALTHAM, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today reported financial results for the third quarter ended September 30, 2024 and prov
NEW YORK, Nov. 1, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the Dow Jones Industrial Average (DJIA) and Dow Jones Utility Average (DJUA) effective prior to the open of trading on Friday, November 8: NVIDIA Corp. (NASD:NVDA) will replace Intel Corp. (NASD:INTC), and The Sherwin-Williams Co. (NYSE:SHW) will replace Dow Inc. (NYSE:DOW) in the Dow Jones Industrial Average. The index changes were initiated to ensure a more representative exposure to the semiconductors industry and the materials sector respectively. The DJIA is a price weighted index, and thus persistently lower priced stocks have a minimal impact on the index. Dow Inc. is also the smallest com
A highly skilled leader with more than 25 years of financial, strategy and business experience at PepsiCo, Lee will oversee Target's finance function and join its leadership teamLee succeeds Michael Fiddelke, Target's chief operating officerMINNEAPOLIS, Sept. 19, 2024 /PRNewswire/ -- Target Corporation (NYSE:TGT) today announced that Jim Lee has been named chief financial officer and a member of its leadership team effective Sept. 22. In his new role, Lee will be responsible for financial planning and analysis, finance capabilities, internal audit, accounting, investor relations, treasury, tax, risk, financial products and services and corporate development. He succeeds Michael Fiddelke, Tar
MONTEVIDEO, Uruguay, Sept. 06, 2024 (GLOBE NEWSWIRE) -- dLocal, a leading cross-border payment platform specializing in high-growth markets, announces the appointment of Carlos Menendez as Chief Operating Officer (COO), effective immediately. Jacobo Singer, who currently serves as COO and Co-President, will continue to serve in both roles during a transition period until December 15, 2024, at which time he will step down from both roles. During this transition period, Carlos and Jacobo will work closely to ensure a smooth handover of responsibilities. Following the transition period, Jacobo will continue to serve as a member of our Board of Directors. "We are excited to welcome Carlos as
Loop Capital reiterated coverage of Apple with a rating of Buy and set a new price target of $275.00 from $300.00 previously
Maxim Group reiterated coverage of Apple with a rating of Hold and set a new price target of $215.00 from $203.00 previously
KeyBanc Capital Markets downgraded Apple from Sector Weight to Underweight and set a new price target of $200.00
4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
To gain an edge, this is what you need to know today. GDP Brings Buying Please click here for an enlarged chart of Invesco QQQ Trust Series 1 (NASDAQ:QQQ). Note the following: The chart shows a drop in QQQ. The drop in QQQ was triggered by speculative sentiment pulling back. As a reader of The Arora Report, you knew in advance that speculative sentiment could fall as a result of Tesla Inc (NASDAQ:TSLA) earnings. The chart shows that QQQ is approaching the support zone. RSI on the chart shows that QQQ is now oversold. Oversold markets tend to bounce. The chart shows that the volume was low on the selloff. This indicates a lack of conviction in selling. Especially hard hit in
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Baird increased Apple Inc. (NASDAQ:AAPL) price target from $200 to $240. Baird analyst William Power maintained an Outperform rating. Apple shares fell 0.1% to trade at $218.51 on Thursday. See how other analysts view this stock. Truist Securities raised the price target for ServiceNow, Inc. (NYSE:NOW) from $750 to $780. Truist Securities analyst Joel Fishbein maintained a Hold rating. ServiceNow shares gained 11.9% to trade at $817.75 on Thursday. See how other analysts view this stock. JP Morg
"Hedging Is Gaining Traction" That's what Goldman Sachs's flow of funds guru Scott Rubner said in his note earlier today ("I Am Not Buying This Dip"). He also pointed out that four of the Magnificent Seven mega caps are reporting earnings next week: Microsoft Corporation (NASDAQ:MSFT), Meta Platforms, Inc. (NASDAQ:META), Apple, Inc. (NASDAQ:AAPL), and Amazon.com, Inc. (NASDAQ:AMZN), and that if their results and guidance are not "great", those stocks will likely get punished in this market environment. In the video below, I show inexpensive ways of hedging Microsoft and Meta ahead of their earnings next week. I mention a couple of times there that there's a link to download the newly
SC 13G/A - ARDELYX, INC. (0001437402) (Subject)
SC 13G - CytomX Therapeutics, Inc. (0001501989) (Subject)
SC 13G - CytomX Therapeutics, Inc. (0001501989) (Subject)
For Immediate Release: September 17, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued a draft guidance, “Integrating Randomized Controlled Trials for Drug and Biological Products into Routine Clinical Practice,” which, when finalized, will support the conduct of randomized controlled trials with streamlined protocols a
For Immediate Release: September 12, 2024 Today, the U.S. Food and Drug Administration authorized the first over-the-counter (OTC) hearing aid software device, Hearing Aid Feature, intended to be used with compatible versions of the Apple AirPods Pro headphones. Once installed and customized to the user’s hearing needs, the Hearing Aid Feature enables compatible versions of the AirPods Pro to serve as an OTC hea
Submission status for ARDELYX INC's drug XPHOZAH (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated
6-K - Alibaba Group Holding Ltd (0001577552) (Filer)
6-K - Alibaba Group Holding Ltd (0001577552) (Filer)
S-3ASR - Apple Inc. (0000320193) (Filer)
4 - ARDELYX, INC. (0001437402) (Issuer)
4 - Apple Inc. (0000320193) (Issuer)
4 - ARDELYX, INC. (0001437402) (Issuer)